Skip to content
value.today

Amgen Inc. vs Pfizer Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Amgen Inc. is the larger company by market value: $249.2 B against $170.7 B for Pfizer Inc., 1.5 times as much (market caps of Oct 30, 2026).
  • Pfizer Inc. had more revenue: $62.6 B against $36.8 B for Amgen Inc., both in the year to December 2025.
  • Pfizer Inc. earned more: net income of $7.8 B against $7.7 B for Amgen Inc.
  • Amgen Inc. keeps more of each dollar of sales: a net margin of 21.0% against 12.4% for Pfizer Inc.
  • Pfizer Inc. employs more people: 75,000 against 25,200 at Amgen Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $834,387 at Pfizer Inc.
  • On price to earnings, Pfizer Inc. trades at 42.3× and Amgen Inc. at 26.5×: investors pay more for each dollar of Pfizer Inc.'s profit.
  • Amgen Inc.'s revenue grew faster in its latest fiscal year: +9.9% against -1.6% for Pfizer Inc.
  • On the Piotroski F-score, a nine-point test of improving finances, Amgen Inc. scores 7 and Pfizer Inc. 5.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

043871301732020202120222023202420252026Amgen Inc. 173Pfizer Inc. 79

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$25B$51B$76B$101B201720182019202020212022202320242025Amgen Inc. $37BPfizer Inc. $63B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAmgen Inc.
AMGN · #74 in the world
Pfizer Inc.
PFE · #127 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19801849
Size
Market cap$249.2 B$170.7 B
Revenue$36.8 B$62.6 B
Net income$7.7 B$7.8 B▲ best
Employees25,20075,000
Valuation
P/E ratio26.5×42.3×
Price to sales6.4×2.7×
Price to book28.8×2.0×
Free cash flow yield3.3%5.3%▲ best
Profitability
Gross margin67.3%74.3%▲ best
Operating margin24.7%—
Net margin21.0%▲ best12.4%
Return on equity106.1%▲ best8.9%
Return on invested capital14.4%—
Growth
Revenue growth9.9%▲ best-1.6%
Revenue growth, 3 years a year11.8%▲ best-14.8%
Earnings per share growth88.2%▲ best-3.5%
Financial strength
Debt to equity6.3×0.7×▲ best
Net debt to EBITDA3.2×—
Interest cover3.3×—
Cash
Free cash flow margin22.0%▲ best14.5%
Shareholder returns
Dividend yield2.1%—
Shareholder yield2.1%—
Strength scores
Piotroski F-score7 of 9▲ best5 of 9
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Amgen Inc. or Pfizer Inc.?

Amgen Inc. is the larger company by market value: $249.2 B against $170.7 B for Pfizer Inc., 1.5 times as much (market caps of Oct 30, 2026).

Which makes more money, Amgen Inc. or Pfizer Inc.?

Pfizer Inc. had more revenue: $62.6 B against $36.8 B for Amgen Inc., both in the year to December 2025. Pfizer Inc. earned more: net income of $7.8 B against $7.7 B for Amgen Inc.

Which is more profitable, Amgen Inc. or Pfizer Inc.?

Amgen Inc. keeps more of each dollar of sales: a net margin of 21.0% against 12.4% for Pfizer Inc.

Which has more employees, Amgen Inc. or Pfizer Inc.?

Pfizer Inc. employs more people: 75,000 against 25,200 at Amgen Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $834,387 at Pfizer Inc.

Is Amgen Inc. cheaper than Pfizer Inc.?

On price to earnings, Pfizer Inc. trades at 42.3× and Amgen Inc. at 26.5×: investors pay more for each dollar of Pfizer Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Which is growing faster, Amgen Inc. or Pfizer Inc.?

Amgen Inc.'s revenue grew faster in its latest fiscal year: +9.9% against -1.6% for Pfizer Inc.

Which is financially stronger, Amgen Inc. or Pfizer Inc.?

On the Piotroski F-score, a nine-point test of improving finances, Amgen Inc. scores 7 and Pfizer Inc. 5.